Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K R Hande

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1986
The effects of cimetidine upon the plasma pharmacokinetics of doxorubicin in rabbitsD E Brenner, J C Collins, K R Hande
Cancer Research|June 1, 1981
Postchemotherapy purine excretion in lymphoma patients receiving allopurinolK R Hande, C V Hixson, B A Chabner
Clinical Chemistry|August 1, 1979
Hyperxanthinemia interferes with serum uric acid determinations by the uricase methodK R Hande, F Perini, G Putterman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Cytochrome P-450IID6 phenotyping in cancer patients: debrisoquin and dextromethorphan as probesL B Anthony, T J Boeve, K R Hande
Cancer Treatment Reports|September 1, 1977
Comparison of nodal primary versus extranodal primary histiocytic lymphomaK R Hande, R R Reimer, R I Fisher
American Journal of Clinical Oncology|June 1, 1987
Disseminated Merkel cell tumor. Treatment with systemic chemotherapyW W Grosh, L Giannone, K R Hande, et al.
Seminars in Oncology|December 1, 1996
Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46)D H Johnson, D M Paul, K R Hande, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapyS N Wolff, W W Grosh, K Prater, et al.
Annals of Internal Medicine|March 1, 1987
Favorable prognosis of brain metastases in small cell lung cancerL Giannone, D H Johnson, K R Hande, et al.
Cancer|January 1, 1991
Current status of etoposide in the management of small cell lung cancerD H Johnson, J D Hainsworth, K R Hande, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Cancer Chemotherapy and Pharmacology|January 1, 1986
The effects of cimetidine upon the plasma pharmacokinetics of doxorubicin in rabbitsD E Brenner, J C Collins, K R Hande
Cancer Research|June 1, 1981
Postchemotherapy purine excretion in lymphoma patients receiving allopurinolK R Hande, C V Hixson, B A Chabner
Clinical Chemistry|August 1, 1979
Hyperxanthinemia interferes with serum uric acid determinations by the uricase methodK R Hande, F Perini, G Putterman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Cytochrome P-450IID6 phenotyping in cancer patients: debrisoquin and dextromethorphan as probesL B Anthony, T J Boeve, K R Hande
Cancer Treatment Reports|September 1, 1977
Comparison of nodal primary versus extranodal primary histiocytic lymphomaK R Hande, R R Reimer, R I Fisher
American Journal of Clinical Oncology|June 1, 1987
Disseminated Merkel cell tumor. Treatment with systemic chemotherapyW W Grosh, L Giannone, K R Hande, et al.
Seminars in Oncology|December 1, 1996
Paclitaxel plus carboplatin in the treatment of patients with advanced lung cancer: a Vanderbilt University Cancer Center phase II trial (LUN-46)D H Johnson, D M Paul, K R Hande, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapyS N Wolff, W W Grosh, K Prater, et al.
Annals of Internal Medicine|March 1, 1987
Favorable prognosis of brain metastases in small cell lung cancerL Giannone, D H Johnson, K R Hande, et al.
Cancer|January 1, 1991
Current status of etoposide in the management of small cell lung cancerD H Johnson, J D Hainsworth, K R Hande, et al.
Pageof 11